Literature DB >> 3790095

Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.

C K Watts, R L Sutherland.   

Abstract

The properties of an antioestrogen binding site (AEBS), which has high affinity and specificity for nonsteroidal antioestrogens and structurally related compounds, have been studied in rat liver microsomes. When subcellular organelles were separated on Percoll density gradients the distribution of the AEBS paralleled that of NADPH-cytochrome c reductase, indicating that the AEBS is associated with the endoplasmic reticulum. Saturation analysis showed that [3H]tamoxifen was bound to a single class of saturable binding sites in liver microsomes with a KD of 0.9 +/- 0.1 nM at 0 degrees C. The equilibrium KD was not significantly different at 22 degrees C. The KD calculated from the association and dissociation rate constants for [3H]tamoxifen binding at 0 degrees C and 22 degrees C was compatible with the KD measured at equilibrium. Ligand specificity studies using tamoxifen analogues showed qualitatively similar structure-affinity relationships for the AEBS from both rat liver and the MCF 7 breast cancer cell line. In general structural modifications caused correspondingly greater changes in affinity for rat liver AEBS than for MCF 7 AEBS. The AEBS was solubilized from microsomal membranes with sodium cholate. This was the only detergent of nine tested that solubilized the site in high yield without loss of activity. Solubilization using cholate was more effective in the presence of 1 M-NaCl. In the solubilized state there was an apparent loss of [3H]tamoxifen binding activity which could be restored by dilution of the detergent. Gel filtration indicated an Mr of 440,000-490,000 for the AEBS-cholate complex. These studies demonstrate that rat liver contains high concentrations of a microsomal AEBS which has similar properties and specificity to the AEBS previously described in human breast cancer cells. This site can be solubilized by sodium cholate to supply material suitable for further purification.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790095      PMCID: PMC1146925          DOI: 10.1042/bj2360903

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat.

Authors:  K Sudo; F J Monsma; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1983-02       Impact factor: 4.736

2.  Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines.

Authors:  M A Miller; B S Katzenellenbogen
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

3.  Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.

Authors:  A Gulino; J R Pasqualini
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

4.  Physicochemical and genetic evidence for specific antiestrogen binding sites.

Authors:  J C Faye; S Jozan; G Redeuilh; E E Baulieu; F Bayard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen.

Authors:  D W Robertson; J A Katzenellenbogen; D J Long; E A Rorke; B S Katzenellenbogen
Journal:  J Steroid Biochem       Date:  1982-01       Impact factor: 4.292

6.  An antiestrogen-binding protein in human tissues.

Authors:  O L Kon
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

7.  Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the Muscarinic receptors.

Authors:  G Ben-Baruch; G Schreiber; M Sokolovsky
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

8.  Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.

Authors:  R C Winneker; J H Clark
Journal:  Endocrinology       Date:  1983-06       Impact factor: 4.736

9.  Modulation of tamoxifen-specific binding sites and estrogen receptors by estradiol and progesterone in the neonatal uterus of guinea pig.

Authors:  A Gulino; J R Pasqualini
Journal:  Endocrinology       Date:  1983-05       Impact factor: 4.736

10.  Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.

Authors:  L C Murphy; R L Sutherland
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

View more
  3 in total

1.  Solubilization of a tamoxifen-binding protein. Assessment of its molecular mass.

Authors:  A Fargin; J C Faye; M le Maire; F Bayard; M Potier; G Beauregard
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

2.  Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site.

Authors:  F Mésange; M Sebbar; B Kedjouar; J Capdevielle; J C Guillemot; P Ferrara; F Bayard; F Delarue; J C Faye; M Poirot
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

3.  Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.

Authors:  I Kawamura; E Lacey; Y Tanaka; F Nishigaki; T Manda; K Shimomura
Journal:  Jpn J Cancer Res       Date:  1994-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.